Mechanisms of Action and Clinical Development of Elotuzumab

David Ritchie; Marco Colonna

doi:10.1111/cts.12532

Mechanisms of Action and Clinical Development of Elotuzumab

David Ritchie
, Marco Colonna

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	261-266
Number of pages	6
Journal	Clinical and translational science
Volume	11
Issue number	3
DOIs	https://doi.org/10.1111/cts.12532
State	Published - May 2018

Access to Document

10.1111/cts.12532

Cite this

@article{eae60d7d47014272a44fe48aa7667507,

title = "Mechanisms of Action and Clinical Development of Elotuzumab",

author = "David Ritchie and Marco Colonna",

note = "Funding Information: Funding. Professional medical writing and editorial assistance provided by Sarah Addison and Cristina Tomas at Caudex was funded by Bristol-Myers Squibb.",

year = "2018",

month = may,

doi = "10.1111/cts.12532",

language = "English",

volume = "11",

pages = "261--266",

journal = "Clinical and translational science",

issn = "1752-8054",

number = "3",

}

TY - JOUR

T1 - Mechanisms of Action and Clinical Development of Elotuzumab

AU - Ritchie, David

AU - Colonna, Marco

N1 - Funding Information: Funding. Professional medical writing and editorial assistance provided by Sarah Addison and Cristina Tomas at Caudex was funded by Bristol-Myers Squibb.

PY - 2018/5

Y1 - 2018/5

UR - https://www.scopus.com/pages/publications/85038841525

U2 - 10.1111/cts.12532

DO - 10.1111/cts.12532

M3 - Review article

C2 - 29272564

AN - SCOPUS:85038841525

SN - 1752-8054

VL - 11

SP - 261

EP - 266

JO - Clinical and translational science

JF - Clinical and translational science

IS - 3

ER -

Mechanisms of Action and Clinical Development of Elotuzumab

Access to Document

Other files and links

Cite this